A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity

Journal of Pharmaceutical Sciences

Volumn 100, Issue 7, 2011, Pages 2778-2789

  Zhang, Fang ^a   Koh, Gar Yee ^a   Jeansonne, Duane P ^a   Hollingsworth, Javoris ^b   Russo, Paul S ^b   Vicente, Graca ^b   Stout, Rhett W ^c   Liu, Zhijun ^a  

^a LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Anticancer; Curcumin; Formulation; Nanoparticles; Rubusoside; Solubility; Stability

Indexed keywords

CHINESE DRUG; CURCUMIN; NANOPARTICLE; PLANT EXTRACT; RUBUSOSIDE; UNCLASSIFIED DRUG;

AEROSOL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ASSAY; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DILUTION; DRUG DEGRADATION; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; LIGHT SCATTERING; PANCREAS CANCER; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 79955622214     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22512     Document Type: Article

References (30)

1. Shukla PK, Khanna VK, Khan MY, Srimal RC. 2003. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 22(12):653-658.
2. Abe Y, Hashimoto S, Horie T. 1999. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39(1):41-47.
3. Pari L, Murugan P. 2007. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail 29(7):881-889.
4. Kang Q, Chen A. 2009. Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol 157(8):1354-1367.
5. Liu D, Schwimer J, Liu Z, Woltering EA, Greenway FL. 2008. Antiangiogenic effect of curcumin in pure versus in extract forms. Pharm Biol 46(10):677-682.
6. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M. 2005. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223(2):181-190.
7. Johnson JJ, Mukhtar H. 2007. Curcumin for chemoprevention of colon cancer. Cancer Lett 255(2):170-181.
8. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ. 2004. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304(5670):600-602.
9. Hanai H, Sugimoto K. 2009. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 15(18):2087-2094.
10. Jordan WC, Drew CR. 1996. Curcumin-A natural herb with anti-HIV activity. J Natl Med Assoc 88(6): 333.
11. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. 2008. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 65(11):1631-1652.
12. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. 2007. Bioavailability of curcumin: Problems and promises. Mol Pharm 4(6):807-818.
13. Kidd PM. 2009. Bioavailability and activity of phytosome complexes from botanical polyphenols: The silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 14(3):226-246.
14. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A. 2007. Polymeric nanoparticle-encapsulated curcumin "nanocurcumin": A novel strategy for human cancer therapy. J Nanobiotechnology 5:3.
15. Li L, Braiteh FS, Kurzrock R. 2005. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104(6):1322-1331.
16. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. 2009. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 371(1-2):148-155.
17. Shishu, Gupta N, Aggarwal N. 2008. Bioavailability enhancement and targeting of stomach tumors using gastro-retentive floating drug delivery system of curcumin-"A technical note". AAPS PharmSciTech 9(3):810-813.
18. Liu A, Lou H, Zhao L, Fan P. 2006. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal 40(3):720-727.
19. Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J. 2007. High-performance liquid chromatography analysis of curcumin in rat plasma: Application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr 21(5):546-552.
20. Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization, and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 29(10):3867-3875.
21. Yadav VR, Suresh S, Devi K, Yadav S. 2009. Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 10(3):752-762.
22. Lapenna S, Bilia AR, Morris GA, Nilsson M. 2009. Novel artemisinin and curcumin micellar formulations: Drug solubility studies by NMR spectroscopy. J Pharm Sci 98(10):3666-3675.
23. Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, Yamada S. 2010. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 99(4):1871-1881.
24. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. 2008. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 70(4):445-449.
25. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG. 2010. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58(4):2095-2099.
26. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ. 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60(2):171-177.
27. Strickley RG. 2004. Solubilizing excipients in oral and injectable formulations. Pharm Res 21(2):201-230.
28. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15(12):1867-1876.
29. Claussen RC, Rabatic BM, Stupp SI. 2003. Aqueous self-assembly of unsymmetric Peptide bolaamphiphiles into nanofibers with hydrophilic cores and surfaces. J Am Chem Soc 125(42):12680-12681.
30. WHO. 2006. Safety evaluation of certain food additives. WHO Food Additive Series 54:117-144.